- Home
- GLTO vs GPUS Comparison
GLTO vs GPUS Comparison
Compare GLTO & GPUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLTO
- GPUS
- Stock Information
- Founded
- GLTO 2011
- GPUS 1969
- Country
- GLTO Denmark
- GPUS United States
- Employees
- GLTO N/A
- GPUS N/A
- Industry
- GLTO Biotechnology: Pharmaceutical Preparations
- GPUS
- Sector
- GLTO Health Care
- GPUS
- Exchange
- GLTO Nasdaq
- GPUS NYSE
- Market Cap
- GLTO 4.4M
- GPUS 4.8M
- IPO Year
- GLTO 2020
- GPUS 1996
- Fundamental
- Price
- GLTO $3.35
- GPUS $1.35
- Analyst Decision
- GLTO Buy
- GPUS
- Analyst Count
- GLTO 1
- GPUS 0
- Target Price
- GLTO $10.00
- GPUS N/A
- AVG Volume (30 Days)
- GLTO 18.8K
- GPUS 2.7M
- Earning Date
- GLTO 08-11-2025
- GPUS 08-15-2025
- Dividend Yield
- GLTO N/A
- GPUS N/A
- EPS Growth
- GLTO N/A
- GPUS N/A
- EPS
- GLTO N/A
- GPUS N/A
- Revenue
- GLTO N/A
- GPUS $93,318,000.00
- Revenue This Year
- GLTO N/A
- GPUS N/A
- Revenue Next Year
- GLTO N/A
- GPUS N/A
- P/E Ratio
- GLTO N/A
- GPUS N/A
- Revenue Growth
- GLTO N/A
- GPUS N/A
- 52 Week Low
- GLTO $2.01
- GPUS $1.23
- 52 Week High
- GLTO $16.07
- GPUS $11.73
- Technical
- Relative Strength Index (RSI)
- GLTO 65.19
- GPUS N/A
- Support Level
- GLTO $3.19
- GPUS N/A
- Resistance Level
- GLTO $3.63
- GPUS N/A
- Average True Range (ATR)
- GLTO 0.24
- GPUS 0.00
- MACD
- GLTO 0.01
- GPUS 0.00
- Stochastic Oscillator
- GLTO 79.37
- GPUS 0.00
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.